Top Markets
Coin of the day
TWi Biotechnology, Inc. TWi Biotechnology, Inc.

TWi Biotechnology, Inc.

6610
Pozycja w akcjach #17309
TWi Biotechnology, Inc. operates as a clinical-stage biopharmaceutical firm,... TWi Biotechnology, Inc. operates as a clinical-stage biopharmaceutical firm, concentrating on the development and sale of medications designed to address innate immunity disorders, primarily within Taiwan. The company's drug pipeline notably includes AC-203, which is currently undergoing Phase 2 clinical trials for various conditions such as epidermolysis bullosa simplex, epidermolysis bullosa, arthritis, gout, and diabetes mellitus. Additionally, AC-1101 is in Phase 1 trials for vitiligo treatment and is advancing through preclinical stages for atopic dermatitis, granuloma annulare, and other uncommon autoimmune skin diseases. TWi Biotechnology has also established a drug development collaboration with Hong Kong Winhealth Pharma Group Co., Limited, targeting the markets of Mainland China, Hong Kong, and Macao. Founded in 2010, the company is headquartered in Taipei, Taiwan.
Cena akcji
$1.21
Kapitalizacja rynkowa
$248.41M
Zmiana (1 dzień)
4.11%
Zmiana (1 rok)
79.12%
Kraj
TW
Handel TWi Biotechnology, Inc. (6610)

Kategoria

Historia ceny akcji dla TWi Biotechnology, Inc. (6610)
Najwyższa cena zamknięcia: $1.18 dnia 2026-09-01

Najniższa cena zamknięcia: $1.95 dnia 2016-12-01
Historia cen akcji firmy TWi Biotechnology, Inc. od 2016 do 2026
Roczna wydajność ceny akcji
Rok Wydajność
2026 (TTM) 43.11%
2025 36.47%
2024 -13.49%
2023 13.07%
2022 -19.33%
2021 0.82%
2020 81.49%
2019 -54.47%
2018 -43.81%
2017 -42.56%
2016 0.00%
Cena akcji podobnych firm lub konkurencji
Firma Cena akcji Zmiana 1r% Kraj
$553.73 38.09%
US
$1.05K 47.97%
NL
$148.19 512.61%
US
$122.21 -10.03%
AU
$757.71 8.20%
CH